Amgen Chairman and CEO Bob Bradway recently joined Bain & Company's Winning with AI podcast for a wide-ranging conversation about how artificial intelligence is reshaping biotechnology, scientific discovery and the future of work.
Hosted by Bain's Sarah Elk and AI pioneer Andrew Ng, the podcast explored why Amgen invested early in AI and data science, how the company is applying AI across its business and what it takes to lead organizational transformation at scale.
Throughout the discussion, Bob emphasized a central theme: AI is fundamentally changing how medicines are discovered, developed, manufactured and delivered to patients.
